Edmond de Rothschild Holding’s Evolent Health EVH Stock Holding History

Edmond de Rothschild Holding’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-40,000	Closed	-$1.14M	–	701
2018 Q3	$1.14M	Sell	40,000 -322,900	-89%	-$7.7M	0.03%	255
2018 Q2	$7.64M	Sell	362,900 -397,100	-52%	-$7.52M	0.22%	98
2018 Q1	$10.8M	Hold	760,000	–	–	0.32%	77
2017 Q4	$9.35M	Buy	760,000 +83,000	+12%	+$1.17M	0.27%	93
2017 Q3	$12.1M	Buy	677,000 +290,000	+75%	+$5.98M	0.34%	80
2017 Q2	$9.81M	Buy	387,000 +25,000	+7%	+$601K	0.28%	89
2017 Q1	$8.07M	Buy	+362,000	New	+$6.95M	0.21%	96

Other funds holding EVH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Edmond de Rothschild Holding's EVH Position: Q4 2018 in Review

Edmond de Rothschild Holding sold out of Evolent Health (EVH) in Q4 2018, closing a stake of 40,000 shares — an estimated $1.14M sold.

Edmond de Rothschild Holding first reported a position in EVH in Q1 2017 and held it in 7 quarters. The position peaked at $12.1M in Q3 2017. 186 funds tracked by Wall St. Rank hold EVH as of Q4 2018.

Edmond de Rothschild Holding reported no remaining Evolent Health position as of Q4 2018 after selling out during the quarter.
Edmond de Rothschild Holding sold 40,000 Evolent Health shares in Q4 2018, an estimated $1.14M.
Edmond de Rothschild Holding first reported a position in Evolent Health in Q1 2017 and held it in 7 quarters.
Edmond de Rothschild Holding's Evolent Health position peaked at $12.1M in Q3 2017.
186 funds tracked by Wall St. Rank held Evolent Health as of Q4 2018.

Based on Edmond de Rothschild Holding's 13F filing for Q4 2018, filed 14 Feb 2019.